Phase II Dose-Finding Study to Evaluate Efficacy and Safety of CDB-2914 in Patients with Uterine Myoma

Trial Profile

Phase II Dose-Finding Study to Evaluate Efficacy and Safety of CDB-2914 in Patients with Uterine Myoma

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Jun 2017

At a glance

  • Drugs Ulipristal (Primary) ; Leuprorelin
  • Indications Uterine leiomyoma
  • Focus Therapeutic Use
  • Sponsors ASKA Pharmaceutical
  • Most Recent Events

    • 20 Jun 2017 Status changed from active, no longer recruiting to completed.
    • 25 Jul 2016 Status changed from recruiting to active, no longer recruiting.
    • 07 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top